Chinook therapeutics revenue
WebFeb 27, 2024 · Chinook Therapeutics GAAP EPS of -$0.90 misses by $0.11, revenue of $0.51M beats by $0.41M Feb. 27, 2024 4:05 PM ET Chinook Therapeutics, Inc. (KDNY) By: Gaurav Batavia , SA News Editor WebChinook Therapeutics Revenue is currently at 51.62 K. Revenue is income that a firm generates from business activities such us rendering services or selling goods to …
Chinook therapeutics revenue
Did you know?
WebFeb 25, 2024 · The revenue for CHK-336 is expected to reach an annual total of $24 mn by 2035 globally based off GlobalData’s Expiry Model. The drug’s revenue forecasts along … WebNov 16, 2024 · Chinook Therapeutics (NASDAQ:KDNY) Third Quarter 2024 ResultsKey Financial Results. Revenue: US$2.50m (up by US$2.50m from 3Q 2024). Net loss: …
WebNov 16, 2024 · Chinook Therapeutics Revenues Beat Expectations, EPS Falls Short. Revenue exceeded analyst estimates significantly. Earnings per share (EPS) missed analyst estimates by 33%. Looking ahead, revenue ... WebAug 8, 2024 · Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, provided a business update and reported financial results for the quarter and six months ended June 30, 2024. ... Revenue – Revenue for the quarter and six months ended …
WebJun 2, 2024 · Conference Call Details. Chinook and Aduro will host a live conference call and webcast on Tuesday, June 2, 2024, at 8:30 am EDT to discuss the proposed transaction. To access the call, please ... WebApr 14, 2024 · The firm had revenue of $5.10 million during the quarter, compared to analyst estimates of $0.10 million. Chinook Therapeutics’s revenue was down 90.0% on a year-over-year basis. As a group, equities analysts forecast that Chinook Therapeutics will post -3.19 earnings per share for the current fiscal year. Insider Activity at Chinook …
WebFeb 27, 2024 · The higher revenue amounts in 2024 were primarily due to $41.2 million non-cash revenue recognized under Chinook’s license agreement with SanReno …
WebApr 13, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical … reachlogixWebApr 13, 2024 · Posted by Defense World Staff on Apr 13th, 2024. Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating) gapped down before the market opened on … how to start a themeWebFeb 26, 2024 · Based on Chinook Therapeutics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.5 million and a GAAP net loss of $55.98 million. how to start a thrift storeWebRevenue in 2024 (TTM): $6.12 M According to Chinook Therapeutics 's latest financial reports the company's current revenue (TTM) is $6.12 M . In 2024 the company made a … reachmakersWebFeb 27, 2024 · The higher revenue amounts in 2024 were primarily due to $41.2 million non-cash revenue recognized under Chinook’s license agreement with SanReno Therapeutics and a $10.0 million milestone ... reachlog ltdWeb1 day ago · Get a real-time Chinook Therapeutics, Inc. (KDNY) stock price quote with breaking news, financials, statistics, charts and more. ... (KDNY) Reports Q3 Loss, Tops … how to start a thrift store businessWebApr 9, 2024 · The firm's quarterly revenue was down 90.0% on a year-over-year basis. Analysts predict that Chinook Therapeutics will post -3.19 EPS for the current year. Insider Transactions at Chinook Therapeutics. In related news, COO Tom Frohlich sold 4,566 shares of Chinook Therapeutics stock in a transaction on Tuesday, January 31st. The … reachmachinery.com